Cite
MLA Citation
S. Banerjee et al.. “2759 Management of nausea and vomiting during treatment with the capsule (CAP) and tablet (TAB) formulations of the PARP inhibitor olaparib.” European journal of cancer, vol. 51, n.d., pp. S550–. http://access.bl.uk/ark:/81055/vdc_100030628283.0x000060